Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Vir Biotechnology Inc
About VIR
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. It also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Tobevibart is an investigational neutralizing monoclonal antibody (mAb) that has been engineered for immune engagement and targets a conserved region on the hepatitis B surface antigen (HBsAg). Elebsiran is an investigational HBV-targeted small interfering RNA (siRNA) that reduces HBsAg. Its pipeline includes VIR-5818, VIR-5500, VIR-5525, and HIV Cure. It also has rights to the PRO-XTEN masking platform for oncology and infectious disease.
Find out what a historical investment in Vir Biotechnology Inc would be worth today using our VIR stock calculator.
Market Capitalisation
$1.52B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
784.17K
High today
$9.29
Low today
$9.03
Open price
$9.07
52-week high
$11.66
52-week low
$4.16
Ready to start your investing journey with Stake?
Open an accountHow do I buy VIR shares in Australia?
Buying VIR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Vir Biotechnology Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in VIR
What is the ticker symbol of Vir Biotechnology Inc?
The ticker symbol for Vir Biotechnology Inc is VIR.
How much is one share of VIR?
One share of VIR is valued at $9.11 as of 22 May 2026.
What is the market capitalisation of Vir Biotechnology Inc VIR?
As of 22 May 2026 Vir Biotechnology Inc has a market cap of $1.52B.
What is the 52-week high for Vir Biotechnology Inc stock?
The Vir Biotechnology Inc 52-week high stock price is $11.66.
What is the 52-week low for Vir Biotechnology Inc stock?
The Vir Biotechnology Inc 52-week low stock price is $4.16.
Can I buy VIR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy VIR shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in VIR on Stake
- Buy VIR from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of VIR from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
VIR related stocks